[go: up one dir, main page]

GB201301307D0 - Crystalline form of prulifloxacin and processes for its preparation - Google Patents

Crystalline form of prulifloxacin and processes for its preparation

Info

Publication number
GB201301307D0
GB201301307D0 GBGB1301307.3A GB201301307A GB201301307D0 GB 201301307 D0 GB201301307 D0 GB 201301307D0 GB 201301307 A GB201301307 A GB 201301307A GB 201301307 D0 GB201301307 D0 GB 201301307D0
Authority
GB
United Kingdom
Prior art keywords
prulifloxacin
processes
preparation
crystalline form
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1301307.3A
Other versions
GB2498107A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of GB201301307D0 publication Critical patent/GB201301307D0/en
Publication of GB2498107A publication Critical patent/GB2498107A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GB1301307.3A 2010-06-30 2011-06-30 Crystalline form of prulifloxacin and processes for its preparation Withdrawn GB2498107A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1920MU2010 2010-06-30
PCT/GB2011/000982 WO2012001357A1 (en) 2010-06-30 2011-06-30 Crystalline form of prulifloxacin and processes for its preparation

Publications (2)

Publication Number Publication Date
GB201301307D0 true GB201301307D0 (en) 2013-03-06
GB2498107A GB2498107A (en) 2013-07-03

Family

ID=44454717

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1301307.3A Withdrawn GB2498107A (en) 2010-06-30 2011-06-30 Crystalline form of prulifloxacin and processes for its preparation

Country Status (3)

Country Link
GB (1) GB2498107A (en)
IN (1) IN2012MN02925A (en)
WO (1) WO2012001357A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102718781B (en) * 2012-05-08 2015-04-29 四川科伦药物研究有限公司 Preparation method of prulifloxacin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0751579B2 (en) 1987-11-07 1995-06-05 日本新薬株式会社 Quinolinecarboxylic acid derivative
BRPI0409930A (en) * 2003-04-30 2006-04-25 Nippon Shinyaku Co Ltd quinolinecarboxylic acid derivative solvate crystals
EP2081940A4 (en) 2006-11-17 2009-12-02 Hetero Drugs Ltd Process for preparation of prulifloxacin using novel intermediates
EP2148883A1 (en) 2007-03-14 2010-02-03 Ranbaxy Laboratories Limited Process for the preparation of pure prulifloxacin
WO2008111018A2 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Process for the preparation of crystals of prulifloxacin
WO2010084508A2 (en) 2009-01-14 2010-07-29 Elder Pharmaceuticals Ltd. Process for the preparation of type i, type ii and type iii crystalline prulifloxacin

Also Published As

Publication number Publication date
GB2498107A (en) 2013-07-03
WO2012001357A1 (en) 2012-01-05
IN2012MN02925A (en) 2015-05-22

Similar Documents

Publication Publication Date Title
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
EP2609120A4 (en) Improved process for preparation of sugammadex
IL222199A0 (en) Process for preparation of dopo-derived compounds and compositions thereof
PL2785701T3 (en) Crystalline form of carbazitaxel and process for preparation thereof
ZA201204365B (en) Darunavir polymorph and process for preparation thereof
ZA201300776B (en) Improved process for the preparation of febuxostat
SI2710015T1 (en) Polymorph of rifaximin and process for the preparation thereof
EP2563768A4 (en) Preparation of febuxostat
PL2528923T3 (en) Process for the preparation of darunavir and darunavir intermediates
EP2573071A4 (en) Preparation method of (s)-4-hydroxy-2-oxo-1-pyrrolidine acetamide
EP2571355A4 (en) Crystalline hydrochloride salt of darunavir
ZA201207397B (en) Process for the preparation of dexlansoprazole
EP2596007A4 (en) Process for the preparation of 17-desoxy-corticosteroids
ZA201300546B (en) Process for the preparation of 3-haloalkylpyrazoles
EP2684869A4 (en) Preparation of 3-mercaptopropionates
IL230977A (en) Crystalline form of rilapladib
PT2655363T (en) Crystalline forms and processes for their preparation
PT2603319E (en) Process for the preparation of urethans
EP2643308A4 (en) Process for the preparation of taurolidine and its intermediates thereof
GB0922023D0 (en) Preparation of n-monofluoroalkyl compounds
GB201301307D0 (en) Crystalline form of prulifloxacin and processes for its preparation
PT2390246T (en) Process for the preparation of aminaphtone
EP2459540A4 (en) Preparation of fipamezole
PL2598504T3 (en) Process for the preparation of dimiracetam
PL389013A1 (en) New vinyl-alkinylsubstituted germanium compounds and process for the preparation of vinyl-alkinylsubstituted germanium compounds

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)